Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
HIV and Acquired Immunodeficiency Syndrome
Home
HIV and Acquired Immunodeficiency Syndrome
HIV and Acquired Immunodeficiency Syndrome
Type here to filter the list
(1114) Association Between State Policies Enabling Pharmacist-initiated HIV Preexposure Prophylaxis and Need for HIV Prevention: An Ecological Analysis
Favorite
(1115) Associations Between Stigma, Social Isolation, Treatment Self-regulation, and Positive and Negative Affect on Adherence Among Individuals with HIV and Substance Use Disorder
Favorite
(1116) College Students’ Perceptions and Barriers to Accessing Pre-exposure Prophylaxis (PrEP) for Prevention of HIV Transmission
Favorite
(1117) Efficacy Outcomes in Virologically Suppressed People Living with HIV-1 Receiving Dolutegravir/lamivudine Across Age Groups: TANDEM Subgroup Analysis
Favorite
(1118) Pharmacist Authority to Initiate Prep & PEP and Participate in Collaborative Practice Agreements
Favorite
(1119) Pharmacy Interventions in Linkage-to-care Services for HIV Pre-exposure Prophylaxis in a Federally Qualified Health Center
Favorite
(1120) Prep up Pharmacies: Preliminary Evidence of a Feasibility Study for Pharmacist-led Same-day Pre-exposure Prophylaxis Screening and Dispensing
Favorite
(1121) Primary Care Medication Monitoring for Prep Patients
Favorite
(1122) Switching to Dolutegravir/lamivudine (DTG/3TC) Is Non-inferior to Continuing Tenofovir Alafenamide (TAF)-Based Regimens at Week 196: TANGO Subgroup Analyses
Favorite
(1123) Vaccine Adherence in People Living with HIV Utilizing Specialty Pharmacy Services in an Outpatient Clinic Setting
Favorite
